SLC22A1 and Cholestatic liver disease: Since the expression of this transcriptional corepressor can be induced by bile acids [86], OCT1 expression is reduced in cholestatic liver disease, when elevated bile acid levels counterbalance the HNF-4α-mediated activation of OCT1 transcription [34].